Monthly Archives: August 2010

CCM disease genes and proteins – The basics of some confusing terminology

The vocabulary of science can be remarkably confusing.  A perfect example of this is the fact that the illness we are discussing has three common and interchangeable names – Cavernous Angioma, Cerebral Cavernous Malformations (CCM), and Cavernoma!  From a research … Continue reading

Posted on by Amy Akers in For Patients | Comments Off

How Common Is Cavernous Angioma?

How often have you been asked “How common is cavernous angioma?” It’s a hard question to answer because there are many different ways to calculate this, and none of them is perfect. We’ve been told the illness is common: 1 … Continue reading

Posted on by Connie Lee in For Patients | Comments Off

The Search for Medications to Treat Cavernous Angioma

In the spring of 2009, we were very excited to announce the first published research indicating that a non-surgical treatment for cavernous angiomas may be on the horizon (Whitehead, 2009). Dr. Kevin Whitehead and his team at the University of … Continue reading

Posted on by Connie Lee in For Patients | Comments Off

Novel approach to studying CCM1 protein function uncovers a new idea for therapeutic intervention.

To move basic research findings from the bench to a treatment for patients, studies must first be done in animal models.  For genetic diseases, a common way of developing an animal model is to genetically engineer mice that are mutant … Continue reading

Posted on by Amy Akers in For Patients, For Professionals | Comments Off